Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Nov 5;11:9353–9369. doi: 10.2147/CMAR.S219689

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Li et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

High MST4 expression is significantly associated with poor prognosis of GC. (A1 and A2) MST4 protein is higher in GCTs than in corresponding ANGMs. (A1) Representative IHC images of low MST4 expression case and high MST4 expression case from training and validation cohort. (A2) IHC score showed GCTs exhibited higher MST4 protein expression than corresponding ANGMs. Box-plot analyzed the differential expression between GCTs and ANGMs from training and validation cohort. IHC, Immunohistochemistry. (B and C) Kaplan-Meier analysis of overall survival (B) and disease-free survival (C) based on MST4 expression in the training cohort. (D and E) Kaplan-Meier analysis of overall survival (D) and disease-free survival (E) based on MST4 expression in the validation cohort. ***P < 0.001.